Michigan Head-Pain Neurological Institute

Ann Arbor, Michigan 48104

2 studies enrolling now · 32 studies all time

What they study most

Acute Migraine, Chronic Migraine, Chronic, Medically Refractory Headache, Cluster Headache, Episodic Migraine, Fibromyalgia, Headache Disorders, Migraine, Migraine Disorders, Migraine Headache, Migraine With Aura, Migraine With or Without Aura

Studies at this site

• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults — Recruiting now
• Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine — Completed
• Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention — Completed
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Acute Treatment Trial in Adult Subjects With Migraines — Completed
• Safety and Efficacy Study in Adult Subjects With Acute Migraines — Completed
• Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches — Completed
• Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia — Completed
• Bion Occipital Nerve Stimulation (ONS) Compassionate Use Study — Completed
• Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache — Completed
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
• Non-Invasive Neurostimulation for the Prevention of Chronic Migraine — Completed
• Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches — Completed
• Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine — Completed
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine — Completed
• Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache — Completed
• Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 — Stopped early
• A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache — Completed
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy — Completed
• Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception — Completed
• Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder — Completed
• Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder — Completed
• Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder — Completed
• A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack — Completed
• Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura — Completed
• Occipital Nerve Stimulation to Treat Chronic Headaches — Completed